Refractive And Visual Outcomes Of A Monofocal Bitoric Intraocular Lens With Plate Haptics In Hyperopic Eyes With Astigmatism
Published 2024
- 42nd Congress of the ESCRS
Reference: PP10.10
| Type: Free paper
| DOI:
10.82333/yav9-m312
Authors:
Francisco Pastor-Pascual* 1
, José Joaquín Muñoz-Tomás 2
, Paz Orts-Vila 2
, Enrique Artiaga-Elordi 2
, José María Marín-Sánchez 3
, Christian García-Elskamp 3
, Pedro Tañá-Rivero 2
1Oftalvist,Valencia,Spain, 2Oftalvist,Alicante,Spain, 3Oftalvist,Murcia,Spain
Purpose
To analyze the refractive and visual outcomes of hyperopic and astigmatic eyes implanted with a monofocal, aspheric, bitoric intraocular lens (IOL) with plate haptics following cataract surgery.
Setting
Oftalvist centers of Alicante, Valencia and Murcia, Spain
Methods
This multi-center prospective study was approved by the Ethics Committee of the Hospital Clínico San Carlos and registered with the National Institutes of Health (NCT05058274). The inclusion criteria were patients with cataracts, regular corneal astigmatism between 1 and 4D, spherical equivalent IOL power implanted between 21 and 26D, hyperopic eyes between 1 and 4D, and white-to-white distance measured with the IOLMaster 700 optical biometer >11.6 mm. Exclusion criteria were history of corneal surgery, irregular cornea, myopic eyes, and ocular abnormalities or diseases that could reduce visual function or postoperative IOL stability.
Results
The study evaluated 51 eyes implanted with the AT TORBI 709M IOL during a follow-up of 12-months. Refractive error, monocular uncorrected distance visual acuity (UDVA), monocular corrected distance visual acuity (DCVA), and the Catquest-9SF questionnaire were analyzed. The mean logMAR UDVA and DCVA were 0.06±0.11 and 0.00±0.08, respectively. 92.16% of the eyes were within ±0.50D and 98.04% were within ±1.00D of a spherical equivalent. 86.27% of the eyes had a refractive astigmatism ≤0.50D and 100% were ≤1.00D. 95% of patients reported being quite satisfied to very satisfied with their vision and about 75% did not report any difficulty with their vision in their everyday life.
Conclusions
The present study shows that the implantation of the AT TORBI 709M IOL in hyperopic and astigmatic eyes was effective and safe. The clinical outcomes obtained in our sample were good and providing high satisfaction level among our patients.